Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy.

AIMS To investigate the influence of interlead distance and lead positioning on success of cardiac resynchronization therapy (CRT) in patients with advanced chronic heart failure and electrical dyssynchrony. Despite application of established selection criteria, 20-40% of the patients do not respond to CRT. METHODS AND RESULTS We examined consecutive patients in whom CRT was implanted. Response to CRT was defined as a decrease in the left ventricular end-systolic volume >or=10% after 6 months. A comparison was made between patients who were responders to CRT and those who were non-responders. A univariate and stepwise multivariate logistic regression was performed with regard to predictors for response. Between January 2004 and January 2008, 174 patients who were treated with CRT were classified as responders [n = 95 (55%)] or non-responders [n = 79 (45%)]. Responders had a significantly larger horizontal interlead distance on the lateral thoracic X-ray [odds ratio (OR) 2.8 (1.2-6.6), P = 0.01], a septal-to-lateral delay >60 ms [OR 4.9 (2.0-11.4), P < 0.0001], non-ischaemic cardiomyopathy [OR 3.0 (1.3-6.9), P = 0.009], a left ventricular end-diastolic diameter <67 mm [OR 4.2 (1.8-9.9), P = 0.001], angiotensin-converting enzyme inhibitor use [OR 8.1 (1.7-38.2), P = 0.008], and no tricuspid valve insufficiency [OR 6.9 (1.3-35.5), P = 0.02]. Post-implantation responders had a significantly greater decrease in the intraventricular delay (septal-to-lateral delay 62 +/- 62 vs. 26 +/- 65 ms, P = 0.001), but not in the interventricular mechanical delay. CONCLUSION Larger interlead distance on the lateral thoracic X-ray, associated with positioning of the left ventricular lead in the posterior position, is associated with response after 6 months of follow-up. Furthermore, diminishing the septal-to-lateral delay is predictive for response.

[1]  E Fleck,et al.  Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure Patients , 2001, Circulation.

[2]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  Jeremy N Ruskin,et al.  Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy. , 2005, The American journal of cardiology.

[4]  Jeroen J. Bax,et al.  Left Ventricular Resynchronization Is Mandatory for Response to Cardiac Resynchronization Therapy: Analysis in Patients With Echocardiographic Evidence of Left Ventricular Dyssynchrony at Baseline , 2007, Circulation.

[5]  Nick Freemantle,et al.  Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. , 2007, European heart journal.

[6]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[7]  Andrew P. Kramer,et al.  Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. , 2003, Journal of the American College of Cardiology.

[8]  H Le Breton,et al.  Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. , 1998, Journal of the American College of Cardiology.

[9]  Jeroen J. Bax,et al.  Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy , 2005, Circulation.

[10]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[11]  Jeroen J. Bax,et al.  Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. , 2006, The American journal of cardiology.

[12]  Stefan Sack,et al.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[13]  J. Blanc,et al.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.

[14]  Andrea Corrado,et al.  Impact of Coronary Sinus Lead Position on Biventricular Pacing: , 2004, Journal of cardiovascular electrophysiology.

[15]  Christophe Leclercq,et al.  Cardiac resynchronization therapy: Part 1--issues before device implantation. , 2005, Journal of the American College of Cardiology.

[16]  B. Kristensen,et al.  Sequential Versus Simultaneous Biventricular Resynchronization for Severe Heart Failure: Evaluation by Tissue Doppler Imaging , 2002, Circulation.

[17]  A. Manolis Cardiac resynchronization therapy in congestive heart failure: Ready for prime time? , 2004, Heart rhythm.

[18]  K. Piestrzeniewicz,et al.  CP07: VENTRICULAR ENDOCARDIAL RIGHT BIFOCAL STIMULATION IN TREATMENT OF SEVERE DILATED CARDIOMYOPATHY HEART FAILURE IN PATIENTS WITH UNSUCCESSFUL BIVENTRICULAR PACEMAKER IMPLANTATION , 2005 .

[19]  R. Doughty,et al.  Predicting outcome in severe heart failure. Who will benefit from device therapy (CRT)? , 2007, European heart journal.

[20]  Catherine Klersy,et al.  Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. , 2006, American heart journal.

[21]  E. Gronda,et al.  Is the Left Ventricular Lateral Wall the Best Lead Implantation Site for Cardiac Resynchronization Therapy? , 2003, Pacing and clinical electrophysiology : PACE.

[22]  J. Daubert,et al.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. , 2002, European heart journal.

[23]  Jeroen J. Bax,et al.  Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. , 2003, The American journal of cardiology.

[24]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[25]  N. Pijls,et al.  Hemodynamic effect of RV apex vs RV septum pacing in a monoventricular and biventricular configuration in patients with heart failure , 2005 .

[26]  M. Gold,et al.  Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapy. , 2005, Heart rhythm.

[27]  Jeroen J. Bax,et al.  Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. , 2006, European heart journal.

[28]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[29]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[30]  E. Foster,et al.  Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[31]  E. Gronda,et al.  Is the Outcome of Cardiac Resynchronization Therapy Related to the Underlying Etiology? , 2003, Pacing and clinical electrophysiology : PACE.

[32]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[33]  N. Pijls,et al.  744 Haemodynamic effect of RV apex vs RV septum pacing in a monoventricular and biventricular configuration in patients with heart failure , 2005 .

[34]  Thomas Lavergne,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay , 2001 .

[35]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.